|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 3261 | Drugs / Medical | 03/22/2004
A class action filed against Walgreen Company on behalf of prescription purchasers who claim that Walgreen’s policy of placing its own expiration dates on prescriptions dispensed wrongly denied them the full and safe use of the medications. Allegedly, Walgreen placed expiration dates of one year from the date of purchase on purchased prescriptions. The action seeks unspecified compensatory damages.
The lawsuit alleges that on at least three specific occasions, Walgreens mislabeled the expiration dates of three prescriptions filled for two women. In two of those instances, the expiration dates were shorter than the actual effective life of the medications. For example, on a prescription for Albuterol filled at a Walgreen Willowbrook, Illinois, pharmacy on September 11, 2000, Walgreen, following its "use before" policy of 365 days, allegedly directed the patient to use the drug before September 11, 2001. The actual expiration date was June 30, 2002. Therefore, the labeling policy resulted in shortening the prescription's effective life from 649 days to 365 days. The same thing allegedly happened with a prescription for Flovent filled at the same pharmacy on the same day-- the patient was directed to use the drug before September 11, 2001, when the actual expiration date was March 31, 2002, shortening the medication's effective life from 567 days to 365 days. The action alleges that these seemingly isolated events is only the tip of the iceberg, exposing a systematic and fraudulent company policy that has existed for the last 10 years. In response to the lawsuit, the company has changed its one-year labeling policy on medicines that are not repackaged at the pharmacy, and for those that are repackaged, the pharmacists are allegedly directed to point out the original manufacturer’s expiration date to customers. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest Children are especially susceptible to lead poisoning, which can result in permanent brain damage. A class action has been filed against the Washington, D.C. Water and Sewer Authority (WASA) on behalf of District residents who allege that the Authority has known that their drinking water was contaminated with lead since the summer of 2001, but didn't take any remedial action or notify the public, in violation of federal environmental law. A class action has been filed against Watson Pharmaceuticals Inc. (NYSE: WPI) and certain of its officers and directors by stockholders who purchased the company's common stock between November 2, 1999, and November 13, 2001. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The parties have reached a $750,000 settlement in an FTC administrative proceeding filed against dietary supplement marketer VisionTel Communications, LLC, on behalf of all persons who purchased Chito-Trim or TurboTone for weight loss, or Impulse Female Herbal Blend/ Maximus Male Herbal Blend for male and female sexual dysfunction. The action alleged that the marketers made deceptive advertising claims about these products in violation of federal consumer protection laws. Persons eligible to take part in the settlement should contact the prosecuting attorneys for more information. The parties have reached a $219,000 settlement in an FTC administrative proceeding filed against nutritional supplement marketer Pinnacle Marketing, LLC, on behalf of all persons who purchased Ultra Carb dietary supplement for weight loss. The action alleged that the marketers made deceptive advertising claims about Ultra Carb in violation of federal consumer protection laws. Persons eligible to take part in the settlement should contact the prosecuting attorneys for more information. Kahn Gauthier Swick, LLC ("KGS") announces that shareholders of Threshold Pharmaceuticals, Inc. ("Threshold" or the “Company”) (Nasdaq:THLD - News) who purchased shares of the Company between February 4, 2005 and July 14, 2006 (the "Class Period"), including purchasers of shares pursuant to Threshold’s February 4, 2005 Initial Public Offering (“IPO”) and its October 12, 2005 follow-on offering, have until September 4, 2007 to move for appointment as Lead Plaintiff in a securities class action lawsuit currently pending in the United States District Court for the Southern District of New York. No class has yet been certified in this action. A tentative settlement was announced in a ten year old class-action lawsuit against a former Warren hospital. The suit was filed in 1995 by two former patients on behalf of 12,000 past hospital patients. The lawsuit claims medical records and personal information files were turned over to a local law firm that wanted to help pay the hospital bills through federal Supplemental Security Income benefits.
|
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
